Literature DB >> 32902780

Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.

Halimat Adedeji-Adenola1, Manimbulu Nlooto2,3.   

Abstract

Background The challenges of under-reporting of adverse drug reactions have been identified as a major setback for the pharmacovigilance system worldwide. Direct reporting by health care consumers has been adopted in some developed and developing countries with a positive impact in improving pharmacovigilance activities through increased reporting rate. There are limited reports on direct reporting and its outcome in Africa. Aim of the review The study aimed to identify and present the available evidence on direct reporting of adverse drug reactions by healthcare consumers in Africa. Methods A review guided by Cochrane handbook was conducted. Electronic scientific databases such as PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase and Cochrane Library were searched. Google scholar, general Google search engine, the website for the regulatory resources for Africa and World Health Organisation-Uppsala Monitoring were also searched for available guidelines, documents and publications. The review period was January 1992 to October 2019. The results were analysed descriptively. Results This study identified 16 African countries that have included healthcare consumers as eligible to report adverse drug reactions in their policy/guidelines. There is low awareness of healthcare consumers on pharmacovigilance system. Eight (8) out of thirty-six (36) African countries that are members of the World Health Organisation Programme for International Drug Monitoring have formally launched direct reporting by healthcare consumers which are 14.2% of African countries. There is a wide range of difference between the rate of adverse drug reactions report submitted by health care consumers as compared with healthcare workers. Paper form, text messages, telephone and web application-based reporting system have been used by different countries that have launched direct reporting. Poor infrastructure, low awareness and lack of a reporting culture are major challenges while the availability of common reporting methods is a potential opportunity of promoting direct reporting in African countries. Conclusions Few African countries have adopted and launched direct reporting. Reporting rate through direct methods is still relatively low when compared with reporting by healthcare workers. Published legal framework, policies, guidelines and studies on direct reporting are limited. Availability of a system and reporting method are opportunities to improve and overcome probable challenges.

Keywords:  Adverse drug reaction; Africa; Direct reporting; Healthcare consumers

Year:  2020        PMID: 32902780     DOI: 10.1007/s11096-020-01141-x

Source DB:  PubMed          Journal:  Int J Clin Pharm


  35 in total

1.  Adverse drug reactions: definitions, diagnosis, and management.

Authors:  I R Edwards; J K Aronson
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

Review 2.  Determinants of under-reporting of adverse drug reactions: a systematic review.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

Authors:  Lise Aagaard; Lars Hougaard Nielsen; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 4.  Specific features of medicines safety and pharmacovigilance in Africa.

Authors:  Ambrose O Isah; Shanthi N Pal; Sten Olsson; Alexander Dodoo; Rachida Soulayami Bencheikh
Journal:  Ther Adv Drug Saf       Date:  2012-02

5.  Low awareness of adverse drug reaction reporting systems: a consumer survey.

Authors:  Jane Robertson; David A Newby
Journal:  Med J Aust       Date:  2013-11-18       Impact factor: 7.738

Review 6.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

7.  Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.

Authors:  Mohammad Nurul Amin; Tahir Mehmood Khan; Syed Masudur Rahman Dewan; Mohammad Safiqul Islam; Mizanur Rahman Moghal; Long Chiau Ming
Journal:  BMJ Open       Date:  2016-08-03       Impact factor: 2.692

8.  Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.

Authors:  Haggar H Ampadu; Jarno Hoekman; Marieke L de Bruin; Shanthi N Pal; Sten Olsson; Daniele Sartori; Hubert G M Leufkens; Alexander N O Dodoo
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

9.  The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study.

Authors:  Helen Byomire Ndagije; Victoria Nambasa; Leonard Manirakiza; Donna Kusemererwa; Dan Kajungu; Sten Olsson; Niko Speybroeck
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  1 in total

1.  Knowledge, perception and practice of pharmaceutical waste disposal among the public in Lagos State, Nigeria.

Authors:  Halimat Adedeji-Adenola; Afusat Adesina; Margaret Obon; Titilayo Onedo; Gladys Ukamaka Okafor; Michealin Longe; Modupe Oyawole
Journal:  Pan Afr Med J       Date:  2022-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.